Development of a Patient-reported Scale to Assess the Acceptability of Percutaneous Physiotherapy Interventions: a Modified Delphi Study (Accept_scale)
August 1, 2026 updated by: Alberto Carcasona Otal, Universidad de Zaragoza
This study aims to develop a new evaluation tool to assess patient acceptability of percutaneous interventions.
A Delphi methodology will be implemented, involving the recruitment of a panel of experts in percutaneous interventions and pain management.
The scale will be developed through several iterative phases until a final version is reached, comprising clearly defined domains, subdomains, items, and questions to be answered by patients in order to obtain an overall acceptability score for the percutaneous technique received.
The scale is intended to be applicable across a wide range of percutaneous interventions and, consequently, to a broad patient population undergoing different percutaneous treatments depending on their clinical condition.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
This study aims to develop a new evaluation tool to assess patient acceptability of percutaneous interventions.
A Delphi methodology will be implemented, involving the recruitment of a panel of experts in percutaneous interventions and pain management.
The scale will be developed through several iterative phases until a final version is reached, comprising clearly defined domains, subdomains, items, and questions to be answered by patients in order to obtain an overall acceptability score for the percutaneous technique received.
The scale is intended to be applicable across a wide range of percutaneous interventions and, consequently, to a broad patient population undergoing different percutaneous treatments depending on their clinical condition.
Study Type
Observational
Enrollment (Actual)
21
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Zaragoza
-
Zaragoza, Zaragoza, Spain, 50009
- University of Zaragoza
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Experts in percutaneous interventions and pain management
Description
Experts were required to:
- have at least five years of experience in percutaneous techniques
- have clinical experience working with patients with pain
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Experts Panel
21 experts (4 women and 17 men) took part in the study.
The expert panel consisted of 14 physiotherapists, 3 psychologists, and 3 physicians
|
The expert panel conducted iterative focus group sessions and successive individual evaluation phases until consensus was reached on the development of the acceptability scale.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Consensus among the experts
Time Frame: Consensus will be achieved through 5 evaluation phases: Day 1 after first focus group Day 7 after second focus group Month 1 after first individual evaluation Month 2 after second individual evaluation Month 4 after second individual evaluation
|
Consensus must be achieved among the experts panel to establish final decisions on the acceptability scale development.
|
Consensus will be achieved through 5 evaluation phases: Day 1 after first focus group Day 7 after second focus group Month 1 after first individual evaluation Month 2 after second individual evaluation Month 4 after second individual evaluation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2025
Primary Completion (Actual)
September 1, 2025
Study Completion (Estimated)
September 1, 2026
Study Registration Dates
First Submitted
January 13, 2026
First Submitted That Met QC Criteria
January 23, 2026
First Posted (Actual)
February 2, 2026
Study Record Updates
Last Update Posted (Actual)
August 4, 2026
Last Update Submitted That Met QC Criteria
August 1, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Acceptability Scale
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Data will be shared on a reasonable request contacting with the main author once data has been published.
Anyway, Individual participant data (IPD) will be shared with other researchers in accordance with data sharing protocols and participant consent, ensuring confidentiality and ethical considerations are maintained.
IPD Sharing Time Frame
Once research has been published
IPD Sharing Access Criteria
Study protocol will be publish in a scientific journal.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.